However, a new CAR-T cell therapy called obecabtagene autoleucel could change this situation. CAR-T therapy (Chimeric Antigen ...

T-cell therapy is a revolutionary immunotherapy approach in which T cells are genetically modified to express a receptor that ...

Aucatzyl is the first CAR-T cell therapy approved by the FDA with no requirement for a risk evaluation mitigation strategy ...

Our additional preliminary studies demonstrate that dual targeting of multiple myeloma cells and BM-CAFs by CAR-T cells is ...

CAR T-cell therapy (Chimeric Antigen Receptor T-cell therapy) is one of the most remarkable breakthroughs in this domain, ...

Most cancer treatments—from chemotherapies to engineered immune cells—have a host of side effects, in large part because they ...

A $2.3 million National Cancer Institute grant will fund a University of Cincinnati Cancer Center study to develop a new ...

Researchers advance CAR T cell therapy for solid tumors by innovating ways to overcome the unique barriers of solid tumor ...

FREDERICK, Md., Nov. 05, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: RNAC) (the “Company”), a clinical-stage biotechnology company pioneering mRNA cell therapy for autoimmune diseases, today announced that ...

Equities researchers at StockNews.com started coverage on shares of Sorrento Therapeutics (NASDAQ:SRNE – Get Free Report) in a report issued on Friday. The brokerage set a “hold” rating on the ...

Researchers have developed an innovative CAR T-cell therapy to combat glioblastoma, the most common malignant brain tumor in ...

Trials with mice in whom the researchers implanted human glioblastoma cells have already shown that the treatment is very ...